In 2024, CAR T-cell therapy continues to transform the landscape of treatment for hematologic malignancies, including multiple myeloma and various forms of lymphoma. Dr. Stefan Ciurea’s comprehensive discussion at a recent medical conference highlighted the significant strides made in this innovative treatment modality, underscoring its potential and challenges. This article delves into the updates, studies, … Continue reading Spotlight on CAR T-cell Therapy in 2024: Advances & Clinical Insights